MedPath

A double-blind randomized controlled trial in the study of the effectiveness of Parent-Child interaction therapy on anxiety and cortisol level in preschool children with parents who use Gul

Phase 1
Completed
Conditions
All stages of the research were performed after obtaining informed written consent from the parents and the verbal consent of the child and based on the latest version of Helsinki Declaration.
Parent&#45
Child interaction therapy&#44
Anxiety&#44
Cortisol level&#44
Preschool children
Registration Number
TCTR20180414004
Lead Sponsor
none
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
64
Inclusion Criteria

The inclusion criteria were: 1) age range of 5-7 years in children; 2) the diagnosis of dependence to Gol with a given dose for at least one of the parents; 3) the diagnosis of anxiety disorder in the child based on DSM- TR; 4) age range of 20 -45 years for parents; and 5) the ability to read and write.

Exclusion Criteria

The exclusion criteria for mothers and children were as follow: 1) lack of natural intelligence with a criterion of less than 70; 2) use of more than three months from psychiatric medications due to the possible effect on the psychological syndrome.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
children's anxiety 12 weeks Spence Children's Anxiety Scale (SCAS)
Secondary Outcome Measures
NameTimeMethod
salivary cortisol 12 weeks enzyme-linked immunosorbent assay (ELISA)
© Copyright 2025. All Rights Reserved by MedPath